METHOD OF TREATING ALLERGY, METHOD OF TREATING ASTHMA, METHOD OF REDUCING RISK OF DEVELOPING INFECTION, AND METHOD OF TREATING CONDITION CHARACTERISED BY CYTOKINE TYPE 1 AND 2 CONTENT IMBALANCE BY β-HYDROXY-β-METHYLBUTYRATE

摘要

FIELD: medicine.;SUBSTANCE: for the purpose of treating allergy in an individual characterised by cytokine Th1 and Th2 imbalance, β-hydroxy-β-methylbutyrate (HMB) is introduced into the individual in an amount effective to reduce cytokine Th1 and Th2 production imbalance. What is also presented is a method of treating allergy in the individual belonging to a risk group of developing allergy.;EFFECT: elimination, delay and reduction of the rate of the onset or severity of allergy-related symptoms due to increase of the cytokine Th1 content with no increase of the cytokine Th2 content.;11 cl, 5 dwg, 8 tbl, 14 ex